Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Elife|January 23, 2020
Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte stateMiri Shnayder, Aharon Nachshon, Batsheva Rozman, et al.
Clinical & Translational Immunology|July 10, 2020
Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cellsHelen M McGuire, Simone Rizzetto, Barbara P Withers, et al.
American Journal of Hematology|May 13, 2022
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplantDavid J Gottlieb, Gaurav Sutrave, Wei Jiang, et al.
Frontiers in Cellular and Infection Microbiology|July 3, 2020
Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral TherapyNicolás M Suárez, Emily Blyth, Kathy Li, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 4, 2021
Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cellsSoi C Law, Thanh Hoang, Kacey O'Rourke, et al.
Blood Advances|January 4, 2018
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cellsBarbara Withers, Emily Blyth, Leighton E Clancy, et al.
Clinical & Translational Immunology|March 22, 2021
Prophylactic antigen-specific T-cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplantDavid Jonathan Gottlieb, Leighton Edward Clancy, Barbara Withers, et al.
Internal Medicine Journal|March 6, 2023
Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysisRichard Blennerhassett, Jad Othman, Amber Biscoe, et al.
Nature Communications|November 27, 2023
CAR+ and CAR- T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignanciesRaymond Hall Yip Louie, Curtis Cai, Jerome Samir, et al.
Transplantation and Cellular Therapy|May 4, 2026
Third-Party Viral Specific T cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCTStella M Davies, Emily Blyth, Catherine M Bollard, et al.
Pageof 6